BioCentury
ARTICLE | Clinical News

Ovarian Cancer Triage Test: Pivotal trial data

March 17, 2008 7:00 AM UTC

In a test on pre-operative serum samples from 450 subjects, Vermillion's biomarker panel in combination with CA-125 vs. CA-125 alone, showed 87% vs. 79% sensitivity, respectively, for detecting stage ...